Human epicardial adipose tissue (EAT) is a visceral and perivascular fat that has been shown to act locally on myocardium, atria, and coronary arteries. Its abundance has been linked to coronary artery disease (CAD) and atrial fibrillation. However, its physiological function remains highly debated. The aim of this study was to determine a specific EAT transcriptomic signature, depending on its anatomical peri-atrial (PA), peri-ventricular (PV), or peri-coronary location.
Introduction
Epicardial fat is a metabolically active visceral and perivascular fat depot, surrounding the myocardium and coronary arteries. There is no fascia separating epicardial adipose tissue (EAT) from muscle or vessels, thus allowing a paracrine dialogue between epicardial adipocytes, cardiomyocytes, and cells of the vascular wall. 1, 2 The secretion of bioactive inflammatory molecules by the EAT is now recognized as implicated in the formation of atherosclerotic plaques, and the onset of coronary artery disease (CAD). 3 -7 The abundance of EAT evaluated by different imaging techniques predicts the number of cardiac events within 8 years, and stent restenosis within 2 years. 8, 9 However, a yin-yang role of EAT cannot be excluded. Beyond its secretory capacities, it has been suggested that this depot has beneficial properties such as protecting the coronary arteries against arterial wave torsion, and the heart against hypothermia. 10 -12 As such, Sacks et al. 13, 14 have observed that EAT exhibited features of beige fat, suggesting that this ectopic fat depot could act as a heat-generating tissue around the heart, increasing energy expenditure by producing uncoupling protein 1 . However, the precursors of epicardial adipocytes are still unknown and come out an increasingly investigated research topic. The function of EAT is also not completely understood, particularly at its different locations around the heart. One of the major limitations in studying the physiology of EAT is that only patients with cardiac diseases undergo cardiac surgery. Collecting EAT from healthy subjects would not be possible for obvious ethical reasons. Necropsic studies have shown that EAT does not develop in a homogeneous manner, and that it preferentially accumulates on the free wall of the right ventricle, at the apex of the left ventricle, around atria, epicardial coronary vessels, and appendages. 15 -17 Could this preferential localization be an indication of a functional difference? Spiroglou et al. 18 reported a different pattern expression of adipokines (adiponectin, visfatin, leptin, chemerin, and vaspin) between pericoronary and apical EAT. The studies carried out on peri-atrial (PA) EAT suggest that the latter are particularly implicated in the incidence of atrial fibrillation, compared with other EAT depots. Nakanishi et al. 19 measured the PA fat in 279 patients suspected of having CAD, and showed that the volume of PA fat predicts the risk of de novo atrial fibrillation within 3 years, with 88% sensitivity and 92% specificity. In vitro studies suggest a local effect of EAT. We have previously shown that human secretory products of EAT, especially adipofibrokines like activin A, induced remodelling of extracellular matrix of rat atrium, ending with myocardial fibrosis. 20 In most studies, the anatomical location of EAT biopsy was not defined or was taken over the right ventricle. Whether EAT is a global entity, or whether each EAT has a specificity depending on its anatomical location is the question we have addressed in this study by a transcriptomic approach.
Objective
The aim of this study exclusively performed in humans was thus to determine a specific EAT signature, depending on its anatomical PA, PV, or peri-coronary location. We thus conducted a pangenomic approach to define a transcriptomic signature of each adipose depot. Our analysis revealed major specific differences in regional EAT's transcriptomic signature involving inflammatory, lipid metabolic, cardiac muscle contraction, and white adipose tissue browning processes.
Methods

Collection of human tissues
The protocol was approved by our local ethics committee of Pitié -Salpêtrière Hospital (Paris) and North Hospital (Marseille). This study was performed in compliance with the Declaration of Helsinki. All patients signed their written informed consent. One hundred and eighteen biopsies (n ¼ 118) of paired thoracic subcutaneous and EAT were taken in the same haemodynamic conditions, a few minutes before the extracorporeal circulation was started. Forty-one biopsies were used for microarray, and 77 for explant analysis (see Supplementary material online, Figure S1 ). EAT was collected at one site per patient to minimize the risk of vessel injury and the duration of surgical procedure.
The biopsies of EAT were taken in the PA region (right atrial appendage, n ¼ 10), PV area (wall of the right ventricle, n ¼ 16), and around pericoronary artery (PCA; at the beginning of the left trunk, between the aorta and the pulmonary artery, n ¼ 15; see Supplementary material online, Figure S2 ). The thoracic subcutaneous paired samples were taken from the sternal wall. Patients underwent cardiac surgery for valve replacement or coronary artery bypass grafting, in cardiac surgery departments of two hospitals in Marseille and Paris. The specimens were immediately frozen (2808C) after collection.
RNA extraction
RNA was extracted using the Qiagen RNA mini-kit (Dusseldorf, Germany), and total RNA concentration was measured by the use of a Nanodrop 1000 spectrophotometer (Thermo Scientific, DE, USA). RNA quality was verified using the Agilent RNA 600 Nano kit (5067-1511; Agilent, Santa Clara, CA, USA) and read with the 2100 Bioanalyser (Agilent Technologies, Massy, France). Only RNA having an RNA Integrity Number over 4 were amplified.
Whole-genome gene expression microarrays
Owing to the small sizes of biopsies, 20 ng of the RNA from each sample was amplified, using the kit Ovation Pico SL WTA System V2 (3312-48; Nugen, Bemmel, The Netherlands). Then, the double-stranded purified cDNA were labelled using an Encore BiotinIL Kit (4210-48; Nugen). The labelled cDNA (150 ng) was hybridized onto pangenomic chips, using the HumanHT-12 v4 Expression BeadChip Kit (BD-103-0604; Illumina, San Diego, USA). The chips containing 47 231 probes for 28 688 coded transcripts were read with an iScan Illumina scanner. Hybridization probe intensities were then detected by GenomeStudio. A quantile normalization procedure, without background, was used to eliminate bad quality signals. 21 The difference in gene expression between the thoracic subcutaneous adipose tissue (SAT) and the EAT was performed by the SAM software (significant analysis of microarray, Stanford University, CA, USA; http:// www-stat.stanford.edu/~tibs/SAM/index.html), which provides a list of significant genes and an estimate of the false discovery rate (FDR) representing the percentage of genes that could be identified by chance. 22 The FDR was tested at 5 and 10%.
RT-PCR and PCR
Quantitative RT-PCR was performed with 50 ng of RNA, 200 U of reverse transcriptase SuperScript II (Life Technologies, Saint-Aubin, France), 50 ng of random primers, 10 mM of nucleotides, and 40 U of the ribonuclease inhibitor RNasin (Promega, Charbonnières, France). Primers for quantitative PCR (QuantiTect Primer assays) were designed by Qiagen (Dusseldorf, Germany). Quantitative PCR was performed using primers labelled with fluorescent Sybrgreen (Eurogentec, Angers, France) and a real-time thermocycler, StepOnePlus (Life Technologies). The 18s ribosomal and GAPDH RNA were used as reference genes to normalize cycle thresholds (C t ) and to get relative quantification (DDC t ), as suggested by others. 23 
Adipose tissue explants
Explants were made from PV, peri-coronary, and subcutaneous fat from a group of 77 patients who had undergone cardiac valve or coronary artery bypass grafting operations (see Supplementary material online, Figure S1 ), 20 samples were common to microarrays, and 57 new patients were included to confirm the results (see their clinical characteristics in Supplementary material online, Table S1 ), and by incubating 50 mg of the tissue in 500 mL of the culture medium DMEM/HAMF12 (Sigma-Aldrich, St Louis, MO, USA) for 24 h at 378C, as previously described. 24 After 24 h of incubation, the samples were centrifuged (10 000 g for 10 min at 48C) and the supernatant was removed and stocked at 2808C, prior to analysis.
Transcriptomic signature of human epicardial adipose tissue Quantification of the omentin secreted was done by ELISA using the Human Omentin-1 (EZH0MNTN1-29K; Millipore, Billerica, MA, USA) ELISA kit.
Western blot
Adipose tissue biopsies were lysed with RIPA (Sigma, Lyon, France), then ground using a Precellys (Ozyme, Montigny-le-Bretonneux, France) tissue homogenizer with CKmix (Ozyme) ceramic beads. The lysates were then centrifuged at 10 000 g for 10 min at 48C. The non-lipid part was removed and placed on a 4 -12% Bis-Tris Nupage (Life Technologies) gel, then transferred onto the nitrocellulose membrane (GE Healthcare, Vé lizyVillacoublay, France). The primary antibody against UCP-1 (U6382; Sigma-Aldrich) was used at a dilution of 1/1000. Detection of the primary antibody was made using fluorescent anti-rabbit secondary antibody (926-32211; LI-COR, Courtaboeuf, France) diluted 1/10 000. Signals were read by an Odyssey Scanner (LI-COR).
Statistical analysis
Statistical analyses were performed using the software R (R software environment for statistical computing; http://www.R-project.org). Samples of EAT biopsies collected at different locations were matched for patients age, BMI, sex, cardiovascular risk factors, coronary status, and cardiac diseases using ANOVA. We further performed multivariate discriminant analysis to evaluate whether the three groups according to EAT location were comparable. The criteria included were age, CAD status, BMI, diabetes, dyslipidaemia, smoking, hypertension, atrial fibrillation, and sex. The expression profile of each gene was analysed using the programme MeV (Multiple Experiment Viewer), which is a Java application dedicated to microarray analysis. The separation of samples into clusters was done by the Genome Studio Software. The differential expression of each gene was carried out without filtering and correction for multiple testing was systematically performed. The significance level was determined according to the q-value of 0.05 or 0.10, which is the adjusted P-value for multiple testing using an optimized FDR approach (as defined by the Benjamini -Hochberg method). q-value was provided by SAMr package under the R statistical software.
The analysis of gene networks was carried out with FunNet 25,26 and presented on Cytoscape, an open source programme networks analysis (Institute of Systems Biology, Seattle, WA, USA). The differences in genes expression quantified by RT-qPCR and the analysis of EAT secretome were performed using the ANOVA and appropriate post hoc test. The level of significance used was P , 0.05.
Results
Characteristics of the population
Forty-one patients (BMI 28.0 + 4.5 kg/m 2 and mean age of 67.3 + 10.4 years) were included in the study. The population studied had a mean LVEF of 57 + 11%, and 54% had CAD ( Table 1) . Sixty-three per cent patients were treated for hypertension, 54% for dyslipidaemia, 29% were type 2 diabetic subjects, and 49% were smokers. The type and severity of CAD or valvulopathy disease was evenly distributed among groups (see Supplementary material online, Table S2 ). Discriminant multivariate analysis showed that the three groups according to EAT location were not different according to age, CAD status, BMI, diabetes, dyslipidaemia, smoking, hypertension, atrial fibrillation, and sex, and that the matching was sufficient to draw analysis ( Figure 1 ).
Specific pattern of EAT reveals a brite/ beige phenotype
The mean number of detected genes was 9700 + 105. Analysis of the hierarchical cluster tree on MeV showed that EAT depots clustered differently from SAT, and that among EAT, PA EAT clustered apart (see Supplementary material online, Figure S3 ). The SAM procedure identified 2123 genes (at FDR ¼ 5) and 2728 (at FDR ¼ 10) significantly overexpressed in the EAT (all depots together), compared with subcutaneous thoracic adipose tissue, whereas 2227 (FDR ¼ 10) genes were significantly down-regulated in EAT, compared with SAT ( Table 2) . See Supplementary material online, Figure S4 annotated with categories of the Kyoto Encyclopedia of Genes and Genomes (KEGG), revealed that total EAT was mainly related to cell -cell interaction, oxidative phosphorylation, and cardiac muscle contraction pathways. Peroxisome proliferator-activated receptor (PPAR) gamma signalling and fatty acid metabolism themes were downregulated in EAT compared with SAT (see Supplementary material online, Figure S4 ). Gene ontology analyses also revealed a specific signature of EAT in muscular differentiation, suggesting a possible 'beige' or 'brite' phenotype. Indeed, EAT expressed certain specific genes of the brown adipose tissue such as ACTA1, actin alpha 1 (ACTC1), PPAR gamma co-activator 1 alpha (PPARGC1A), troponin C type 1, and troponin I type 1. In addition, the homeobox C9 (HOXC9) gene was significantly down-regulated in EAT compared with SAT, translating into an intermediary 'beige' or 'brite' profile of EAT (Figure 2 ). While we were not able to detect UCP-1 gene in our microarray setting (FDR .10), UCP-1 gene expression evaluated by qPCR was significantly up-regulated in EAT In agreement, UCP-1 protein was significantly increased in EAT, using western blotting (Figure 2 ).
Common EAT characteristics
We further focused on EAT-enriched genes. Venn diagram analysis identified that the three groups of EAT shared 400 common genes ( Figure 3A ; see Supplementary material online, Table S3 ). Gene ontology analysis revealed that these 400 genes are involved in biological processes including (i) extracellular matrix remodelling, associated with collagen IV, VI, thrombospondin 3, laminin alpha 2, fibronectin 1 genes; (ii) thrombosis, together with tissue plasminogen activator, prostaglandin D2 synthase (PTGDS), and inflammatory/infectious sPLA2-IIA (Group IIA secretory phospholipase A2) genes, as shown previously 24 ; and (iii) inflammation/infection, associated with genes encoding complement factors ( Figure 3B ). Among these shared genes, ITLN1 (omentin), synaptotagmin IV (SYT4), complement factor B (CFB), ezrin (EZR), indolethylamine N-methyltransferase (INMT), proteoglycan 4 (PRG4), and arachidonate 15-lipoxygenase (ALOX15) genes were highly up-regulated compared with SAT (2.27 -13.73-fold-change, q-value ¼ 0.00). These results were confirmed using RT-qPCR and showed that these seven genes were the most abundantly expressed genes in EAT (Figure 4) . Omentin (ITLN1) was the most up-regulated gene in EAT (fold-change .12).
Gene network analysis with cytoscape showed that omentin was closely co-expressed with 79 other genes (see Supplementary material online, Table S4 ), suggesting an important connecting role for this adipokine ( Figure 5 ).
Specific signatures characterize different EAT depots
Beige signature was particularly pronounced in the PV EAT, as UCP-1 expression was five-fold higher in PV EAT compared with PA EAT (P ¼ 0.01), P ¼ 0.08 compared with the peri-coronary EAT by trend ( Figure 2 ). Omentin expression was significantly higher in PV EAT, compared with other EAT depots. Omentin secretion was also highly increased in the PV EAT compared with the subcutaneous and the pericoronary EAT (both, P , 0.0001), in agreement with qPCR results. However, due to the tiny size (,20 mg of tissue) of the biopsies obtained from the PA EAT, omentin secretion measurements were not available in this tissue ( Figure 5 ). Remarkably, we observed a specific expression signature for PA, PV, and peri-coronary EAT. We precisely identified 2571 genes enriched in PA EAT, 622 genes enriched in PV EAT, and 1170 in peri-coronary (PCA) No., number; PCA, peri-coronary artery; PV, peri-right ventricle; PA, peri-atrial.
EAT. PA EAT was identified as the most atypical EAT, with regard to pangenomic profile (see Supplementary material online, Figure S3 ). Network analyses of these genes using FunNet showed that the PV EAT overexpressed genes remarkably implicated in Notch/p53 (CHK1, DAAM1, IGF1, and SHISA5), inflammation (TNF-R1, STAT1, and SERPING1), ABC transporters (ABCA8 and ABCD4), or glutathione metabolism (GSTO2, GSR, and GSTP1). The peri-coronary EAT overexpressed genes implicated in proliferation (CycB, CycE1, CycD, and CDK6), O-N glycan biosynthesis (GTB, CD68, POFUT2, and ALG6), and sphingolipid metabolism (GLB1, SGPP2, and SIAL3). The PA EAT overexpressed genes implicated in oxidative phosphorylation (COXs and ATPs), cell adhesion (ANKRD1, TNC, and COL4A4), cardiac muscle contraction (TNNI3, TPMs, ACTC1, and MYH6), and intracellular calcium signalling pathway (SERCA1, CAMK2B, CAMK2D, and NCX2), suggesting a specific contribution of PA EAT to cardiac muscle activity ( Figure 6 ).
The differences shown in the three EAT gene expression were not linked to patients' characteristics, as the expression of adiponectin, leptin, HOXC9, PGC1a, EZR, INMT using PCR, and microarrays were similar in their subcuteanous adipose tissue counterpart (Figures 7 and 8 ).
Discussion
Using gene-profiling analysis, we here described that the EAT presents different characteristics from the thoracic SAT, and especially shows an overexpression of gene characteristics of a 'beige'/'brite' phenotype.
The novelty of our work is to propose a new transcriptomic characterization of EAT, depending on its anatomical cardiac localization.
Common EAT gene profile
First, the three EAT depots share highlighting of inflammation, extracellular matrix remodelling, and thrombosis pathways. This strengthens previous observations describing the differences between abdominal visceral and SAT located in the periumbilical area in obese patients. 27 -29 It has also been reported that EAT is more inflamed than SAT, particularly in CAD patients; it secretes pro-inflammatory cytokines such as TNF-a, IL-6, MCP-1, IL-1b, and NLRP3, and is infiltrated by immune cells, especially by macrophages with an M1 profile. 6, 7, 30 Few studies compared the transcriptomic profiles of EAT with those of visceral adipose tissue, since both abdominal and thoracic cavities need to be opened simultaneously to reach tissues. Only, Imoto-Tsubakimoto et al. 31 have shown the up-regulation of 55 genes implicated in the inflammatory immune response in EAT vs. visceral abdominal adipose tissue. Among these 55 genes, 35 genes, including IL-1b, IL-6, IL-8, and the chemokine receptor 2 genes, were expressed twice as much in the EAT than in the visceral adipose tissue, suggesting that the EAT, although it represents ,1% of the global adipose tissue mass, is more inflamed than the visceral abdominal depot. Taken together with the induction of pro-inflammatory factors, we confirmed observations showing that EAT is characterized by a signature of extracellular matrix and remodelling genes including collagen types, profibrotic factors, and remodelling enzymes. The induction of the extracellular matrix remodelling genes in the visceral adipose tissue of mice kept on a high fat diet has already been described. 32 Similar findings were reported in the subcutaneous and omental adipose tissue of obese subjects. 27, 33 At variance of other adipose depots, the abundance of epicardial fat fibrosis has never been properly quantified. Nevertheless, this expression and secretion of profibrotic factors may have functional consequences on the adjacent myocardium and atrium.
As such, we have previously shown that the secretory products of EAT can induce myocardial fibrosis of rat atria. 20 In addition, our group has previously described the induction of genes implicated in thrombosis, especially sPLA2-IIA (Group IIA secretory phospholipase A2) in EAT, a phospholipase present in atherosclerotic lesions, which has a crucial role in the pro-inflammatory cascade. 24 Overexpression of PTGDS in EAT has also been already observed elsewhere. 34 The similarities observed in other studies further substantiate our data and strengthen the hypothesis that EAT is implicated in inflammatory, immune, and remodelling processes, independently of CAD status. Transcriptomic signature of human epicardial adipose tissue
Beige phenotype
Secondly, we have shown that EAT could have a 'beige' profile, due to the overexpression of UCP-1, and to several genes characterizing adipose tissue 'browning'. The 'brite' (i.e. brown in white) or 'beige' adipocytes are multi-locular adipocytes located within white adipose tissue islets, which have the capacity to be recruited and to express UCP-1, mainly in case of cold exposure. Beige adipocytes do not come from the dermomyotomal precursor shared by brown adipose tissue and muscle. 35 -37 These adipocytes have a specific molecular signature, which is currently being identified, and coexist with brown adipose tissue. 38 -40 Sacks et al. 13, 14 have reported beige molecular signature of EAT taken from the start of the right coronary artery. Our results corroborate those of Sacks et al., and show in addition that the PV EAT could be the more sensitive to 'browning'. This has to be confirmed in functional studies. Genes enriched in PV EAT encode enzymes of the glutathione metabolism pathway. The enzymes, implicated in the metabolism of glutathione, have a specific signature in brown adipose tissue, due to the decoupling of the respiratory chain, the increase in oxidative metabolism, and H 2 O 2 production. 41 It has been proposed that beige adipose tissue in EAT originates from the recruitment of white adipocytes whose browning is induced by factors such as myokines or growth factors like irisin, FGF21, or cardiac natriuretic peptides (atrial natriuretic peptide/brain natriuretic peptide). 40, 42 Whether these factors have a direct paracrine effect on EAT remains to be determined.
Omentin
We have observed that one of the most expressed genes in EAT was omentin (ITLN-1) . This adipokine is secreted markedly by EAT as opposed to the SAT. It has already been reported that omentin has beneficial anti-inflammatory properties, and that it promotes insulin sensitivity. 43, 44 Studies have shown that omentin ameliorates endothelial function, and reperfusion after ischaemia, by increasing the production of nitric oxide by endothelial NO synthase. 45 -47 Its plasma level decreases in obesity and in type 2 diabetes. 48, 49 Fain et al. 50 have shown that it was secreted by the stromal vascular fraction of EAT. Greulich et al. 51 showed that contractile dysfunction of cardiomyocytes exposed to EAT conditioned media of diabetic patients was improved by the addition of recombinant omentin in vitro. As a whole, this gene expression study confirms the fact that EAT produces factors having both positive and deleterious effect on the heart.
Specific transcriptomic signature of EAT
Our observations are substantiated by the identification of a transcriptomic signature associating with perivascular (peri-coronary), PA, or PV anatomical location. While most studies use samples taken from regions close to the root of the right coronary artery, 6, 13 we identify for the first time signatures of gene enrichments for each of the pericoronary, PV, and PA EAT. At variance of our expectation, we observed that peri-coronary EAT is not the more pro-inflammatory depot at least at the gene expression level. PV EAT appears more closely linked to the genes involved in inflammation and immunity processes. PV EAT is also characterized by genes of the A, B, and C transporters, which are implicated in cellular detoxification and intracellular lipid transport.
52,53
The peri-coronary EAT associates with cyclin and cell cycle pathway genes, but also with the sphingolipid metabolism pathway. Sphingolipids are complex lipids present in atherosclerotic plaques. They induce aggregation and retention of oxidized LDL and VLDL in the subendothelial space, which in turn increases the capture of aggregated lipoproteins by macrophages and their transformation into foam cells. 54, 55 Owing to its perivascular location, the peri-coronary EAT seems to be more implicated in atherogenesis. It can also be hypothesized that the activation of the sphingolipid pathway is a sign of toxic lipid derivatives accumulation in the vascular wall. One could also suggest that the peri-coronary EAT is implicated in the transfer of 'outside in' lipids, from the EAT towards systemic circulation. Finally, we observed that the PA EAT is an atypical adipose tissue, different from the other two EATs, by expressing genes implicated in oxidative phosphorylation, muscular contraction, and calcium signalling. This is in accordance with the study of Nakanishi et al. 19 that has found an association between PA EAT and new-onset non-valvular atrial fibrillation. The SERCA1 gene, which is significantly overexpressed in the PA EAT, codes for a Ca 2+ /ATP-dependent intracellular pump that translocates the cytosolic calcium into the lumen of the sarcoplasmic reticulum, and promotes excitation -contraction coupling. 56, 57 Furthermore, induction of genes, such as heavy chains of myosin and tropomyosins, is in favour of a strong interaction between PA EAT and cardiac muscle. 58 However, the presence of genes coding for proteins implicated in cardiomyocyte contraction questions the type of 
Limitations
This study has several limitations: the analysis of samples from healthy subjects would have been more interesting to study the EAT physiology. However, this was not possible for obvious ethical reasons, and cardiac surgery is the only way to get EAT biopsies, implying to adjust the samples for cardiovascular risk factors, CAD, and atrial fibrillation status. Paired biopsies of the four locations from the same patients would have been more accurate to draw analyses and conclusions, but would have significantly increased the time and risk of the procedure. However, similar gene expression was found in the subcutaneous fat of the three groups of patients with EAT biopsies, suggesting that the differences shown in our work were not due to differences in patients characteristics but to differences in tissue characteristics. Furthermore, discriminant multivariate analysis showed that we could not discriminate the three groups of EAT according to clinical parameters. As such, specific transcriptomic signature depending on anatomical location of EAT is likely, but needs to be explored further in both clinical and experimental settings. In this study, we provided one comprehensive list of transcriptomic signatures that characterize EAT depots associated with anatomical locations. This could suggest different functions with respect to the structures adjacent to it, and reveals the importance of taking into account the origin of EAT biopsies or explants in further in vitro studies. For in vivo future clinical research, our study reveals that it is important not to consider EAT as a whole entity but to focus on each compartment. Imaging assessment of each EAT compartment might add a value in the risk of CAD, and decrease the time of post-processing computed tomography or magnetic resonance imaging measurements. Furthermore, our study provides another illustration that EAT expresses and secretes molecules, which could have a deleterious but also a cardioprotective effect as shown for omentin. Thus, limiting the role of EAT to a harmful effect on the vascular wall and on cardiac function would be very reductive. The implication of EAT in the pathophysiology of CAD is probably the result of an imbalance between pro-inflammatory, proatherogenic bioactive molecules, and cardioprotective insulinsensitizing molecules such as omentin. 59 Our study provides additional information regarding the central place occupied by ectopic fat on local organ metabolism and function, and will bring new insights in adipocyte -myocyte cross-talk and pathophysiology.
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